Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia

British Journal of Haematology

Volumn 119, Issue 1, 2002, Pages 46-53

  Tzoanopoulos, Dimitrios ^a   Speletas, Matthaios ^b   Arvanitidis, Konstantinos ^a   Veiopoulou, Christina ^c   Kyriaki, Sofia ^a   Thyphronitis, George ^c   Sideras, Paschalis ^d   Kartalis, Georgios ^a   Ritis, Konstantinos ^a,e  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d LUND UNIVERSITY   (Sweden)

^e NONE   (Greece)

Author keywords

Chronic myeloid leukaemia; Exon skipping; Interferon; IRF 1; Non isotopic RNase cleavage assay

Indexed keywords

ALPHA2B INTERFERON; HYDROXYUREA; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA;

ARTICLE; BLAST TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE INACTIVATION; HUMAN; MONONUCLEAR CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; DISEASE PROGRESSION; DNA-BINDING PROTEINS; EXONS; HUMANS; INTERFERON REGULATORY FACTOR-1; LEUKEMIA, MYELOID, CHRONIC; PHOSPHOPROTEINS; POINT MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036401775     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03829.x     Document Type: Article

References (37)

1. Bala, S., Kraus, C., Wijnen, J., Meera Khan, P. & Ballhausen, W.G. (1996) Multiple products in the protein truncation test due to alternative splicing in the adenomatous polyposis coli (APC) gene. Human Genetics, 98, 528-533.
2. Barthe, C., Mahon, F.-X., Gharbi, M.-J., Fabères, C., Bilhou-Nabéra, C., Hochhaus, A., Reiffers, A. & Marit, G. (2001) Expression of interferon-α (IFN-α) receptor 2c at diagnosis is associated with cytogenetic response in IFN-α- treated chronic myeloid leukemia. Blood, 97, 3568-3573.
3. Eicheler, W., Zips, D., Dorfler, A., Grenman, R. & Baumann, M. (2002) Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. Journal of Histochemistry and Cytochemistry, 50, 197-204.
4. Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R. & Kantarjian, H. (1999) The biology of chronic myeloid leukemia. New England Journal of Medicine, 341, 164-172.
5. Fischer, T., Aman, J., van der Kuip, H., Rudolf, G., Peschel, C., Aulitzky, W.E. & Huber, C. (1996) Induction of interferon regulatory factors, 2′-5′ oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness. British Journal of Haematology, 92, 595-603.
6. Goldrick, M.M., Kimball, G.R., Liu, Q., Martin, L.A., Sommer, S.S. & Tseng, J.Y. (1996) NIRCA: a rapid robust method for screening for unknown point mutations. Biotechniques, 21, 106-112.
7. Gordon, M.Y. & Goldman, J.M. (1996) Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment. British Journal of Haematology, 95, 10-20.
8. Green, W.B., Slovak, M.L., Chen, I.-M., Pallavicini, M., Hecht, J.L. & Willman, C.L. (1999) Lack of IRF-1 expression in acute pro-myelocytic leukemia and in a subset of acute myeloid leukemias with del (5) (q31). Leukemia, 13, 1960-1971.
9. Harada, H., Fujita, T., Miyiamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T. & Taniguchi, T. (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell, 58, 729-739.
10. Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M. & Taniguchi, T. (1993) Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science, 259, 971-974.
11. Harada, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M.S., Hirai, H. & Taniguchi, T. (1994) Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene, 9, 3313-3320.
12. Hochhaus, A., Yan, X.H., Willer, A., Hehlmann, R., Gordon, M.Y., Goldman, J.M. & Melo, J.V. (1997) Expression of interferon regulatory factor (IRF) genes and response to interferon-α in chronic myeloid leukaemia. Leukemia, 11, 933-939.
13. Holtschke, T., Löchler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J.F., Bachmann, M.F., Zinkernagel, R.M., Morse, H.C. III, Ozato, K. & Horak, I. (1996) Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell, 87, 307-317.
14. Itoh, S., Harada, H., Nakamura, Y., White, R. & Taniguchi, T. (1991) Assignment of the human interferon regulatory factor-1 (IRF1) gene to chromosome 5q23-q31. Genomics, 10, 1097-1099.
15. Kantarjian, H.M., Smith, T.L., O'Brien, S., Beran, M., Pierce, S. & Talpaz, M. (1995) Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. Annals of Internal Medicine, 122, 254-261.
16. Kimura, T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilček, J., Mak, T.W. & Taniguchi, T. (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science, 264, 1921-1924.
17. Le Beau, M.M., Albain, K.S., Larson, R.A., Vardiman, J.W., Davis, E.M., Blough, R.R., Golomb, H.M. & Rowley, J.D. (1986) Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes, 5 and 7. Journal of Clinical Oncology, 4, 325-345.
18. Mamane, Y., Heylbroeck, C., Génin, P., Algarté, M., Servant, M.J., LePage, C., DeLuca, C., Kwon, H., Lin, R. & Hiscott, J. (1999) Interferon regulatory factors: the next generation. Gene, 237, 1-14.
19. Maruyama, M., Fujita, T. & Taniguchi, T. (1989) Sequence of a cDNA coding for human IRF-1. Nucleic Acids Research, 17, 3292.
20. Nimer, S.D. & Golde, D.W. (1987) The 5q- abnormality. Blood, 70, 1705-1712.
21. Nozawa, H., Oda, E., Ueda, S., Tamura, G., Maesawa, C., Muto, T., Taniguchi, T. & Tanaka, N. (1998) Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer (1998). International Journal of Cancer, 77, 522-527.
22. Park, K.C., Shimizu, K., Hayakawa, T. & Tanaka, N. (1998) Regulation of interferon responses in medulloblastoma cells by interferon regulatory factor-1 and -2. British Journal of Cancer, 77, 2081-2087.
23. Preisler, H.D., Perambakam, S., Li, B., Hsu, W.T., Venugopal, P., Creech, S., Sivaraman, S. & Tanaka, N. (2001) Alterations in IRF1/IRF2 expression in acute myelogenous leukemia. American Journal of Hematology, 68, 23-31.
24. Ritis, K., Speletas, M., Tsironidou, V., Pardali, E., Kanariou, M., Moschese, V., Orlandi, P., Skordala, M., Rossi, P., Kartalis, G., Bourikas, G. & Sideras, P. (1998) Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia. British Journal of Haematology, 102, 1241-1248.
25. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Analysis and cloning of eykaryotic genomic DNA. In: Molecular Cloning: a Laboratory Manual (ed. by N. Ford, C. Nolan & M. Ferguson), 2nd edn. chapter 9, pp. 45-46. Cold Spring. Harbor Laboratory Press, New York.
26. Sawyers, C.L. (1999) Chronic myeloid leukemia. New England Journal of Medicine, 340, 1330-1340.
27. Schaper, F., Kirchhoff, S., Posern, G., Köster, M., Oumard, A., Sharf, R., Levi, B.Z. & Hauser, H. (1998) Functional domains of Interferon regulatory factor I (IRF-1). Biochemistry Journal, 335, 147-157.
28. Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J.F., Rosenbauer, F., Huhn, D., Witting, B., Horak, I. & Neubauer, A. (1998) Lack of Interferon Consensus Sequence Binding Protein (ICSBP) transcripts in human myeloid leukemias. Blood, 91, 22-29.
29. Schmidt, M., Hochhaus, A., Nitsche, A., Hehlmann, R. & Neubauer, A. (2001) Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α. Blood, 97, 3648-3650.
30. Schneider, S., Wildhardt, G., Ludwig, R. & Royer-Pokora, B. (1993) Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations. Human Genetics, 91, 599-604.
31. Speletas, M., Arvanitidis, K., Tzoanopoulos, D., Tsironidou, V., Pardali, E., Aggeli, C., Tsapogas, P., Kartalis, G., Sideras, P. & Ritis, K. (2001) Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: a study of 77 Greek patients. Haematologica, 86, 918-927.
32. Stark, G.R., Kerr, I.M., Williams, R.G.B., Silverman, R.H. & Schreiber, R.D. (1998) How cells respond to interferons. Annual Reviews of Biochemistry, 67, 227-264.
33. Tada, S., Saito, H., Ebinuma, H., Wakabayashi, K., Masuda, T. & Ishi, H. (1998) Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-α in human hepatoma cell lines. International Journal of Oncology, 13, 1207-1216.
34. Talpaz, M., McCredie, K.B., Mavligit, G.B. & Gutterman, J.U. (1983) Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood, 62, 689-692.
35. Talpaz, M., Kantarjian, H.M., McCredie, K.B., Trujillo, J.M., Keating, M.J. & Gutterman, J.U. (1986) Hematologic remissions and cytogenetic improvement induced by recombinant human interferon-alpha in chronic myelogenous leukemia. New England Journal of Medicine, 314, 1065-1069.
36. Taniguchi, T., Lamphier, M.S. & Tanaka, N. (1997) IRF-1: the transcription factor linking the interferon response and onco-genesis. Biochimica et Biophysica Acta, 1333, M9-M17.
37. Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. (2001) IRF family of transcription factors as regulators of host defence. Annual Reviews of Immunology, 19, 623-655.